EcoDrugPlus

Ensembl ID : ENSSVLG00005025899
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSSVLG00005016810
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSSVLG00005003490
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSSVLG00005002903
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSSVLG00005007115
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSSVLG00005023015
Gene Symbol: -
Cross references: -
658 Possible Orthologues:

Ensembl ID : ENSSVLG00005022805
Gene Symbol: -
Cross references: -
632 Possible Orthologues:

Ensembl ID : ENSSVLG00005020462
Gene Symbol: -
Cross references: -
322 Possible Orthologues:

Ensembl ID : ENSSVLG00005018453
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSSVLG00005006912
Gene Symbol: -
Cross references: -
48 Possible Orthologues:

Ensembl ID : ENSSVLG00005010636
Gene Symbol: -
Cross references: -
136 Possible Orthologues:

Ensembl ID : ENSSVLG00005009444
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).